Progress in the application of novel oral anticoagulants in advanced chronic kidney disease
Patients with advanced chronic kidney disease(CKD)have a higher risk of venous thromboembolism and atrial fibrillation and need to receive anticoagulant therapy.At the same time,patients with advanced CKD also have an increased risk of bleeding,which complicates antithrombotic therapy.Therefore,special attention should be paid to the rational selection and use of anticoagulant drugs in advanced CKD patients.The application of novel oral anticoagulant in advanced CKD patients is noteworthy because of the rapid effect,short half-life and no need for laboratory indicator monitoring.
new oral anticoagulantadvanced chronic kidney diseaseend-stage renal diseaseatrial fibrillationhemorrhage
万方数据
维普
